Search | IOVS | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Bilamellar Tarsal Rotation (BLTR) vs Posterior Lamellar Tarsal Rotation (PLTR) for Trachomatous Trichiasis (TT)

John H Kempen; Yineng Chen; Aida Abashawl; Ahlam Awad Mohammed; Sarity Dodson; Wondu Alemayehu; Alemu Gemechu; Dereje Adugna; Aemero Abateneh; Tony Succar; Vatinee Y Bunya; Kathy McWilliams; Maureen G Maguire; Matthew Burton; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2813.

ARVO Annual Meeting Abstract June 2024

Impact of Varenicline Solution Nasal Spray on Tear Film Cytokine Levels in Subjects with Sjogren’s Disease

Taylor J. Linaburg; Angela Satya Gupta; Puja Shah; Marian Macsai; Eric Carlson; Emma Iacobucci; Vatinee Y Bunya; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2967.

Cornea January 2024

Sjögren's Versus Non-Sjögren's Ocular Features: Similar Symptoms, But Significantly Worse Signs

PDF

Fanxiu Xiong; Douglas Pula; Esen K. Akpek; Vatinee Y. Bunya; Caroline H. Shiboski; Thomas L. Lietman; John A. Gonzales
TAGS: ocular signs and symptoms, signs and symptoms, sjogren's syndrome, dry eye syndromes
Invest. Ophthalmol. Vis. Sci.. 2024; 65(1):23. https://doi.org/10.1167/iovs.65.1.23

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Efficacy of OC-01 0.03mg varenicline nasal spray in the treatment of Sjogren’s Disease

Angela Satya Gupta; Vivian Qin; Brian Jonathan Nguyen; Vatinee Y Bunya; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3941.

ARVO Annual Meeting Abstract June 2023

Corneal Epithelial Thickness in Sjogren’s Syndrome

Brian Jonathan Nguyen; Angela Satya Gupta; Jocelyn He; Gui-Shuang Ying; Vatinee Y Bunya; Ilaria Macchi; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3938.

ARVO Annual Meeting Abstract June 2023

Two-Year Progression of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Daniel Lee; Yinxi Yu; Vatinee Y Bunya; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3964.

ARVO Annual Meeting Abstract June 2023

Increased prevalence of novel antibodies in Sjögren’s patients compared to non-Sjögren’s dry eye patients

David Hsu; Yinxi Yu; Esen K Akpek; Lee Guo; Tiffany Liu; Mina Massaro-Giordano; Sou Abboud; Franz Fogt; Devica Bhutani; Emma Iacobucci; Jay Pendyala; Joan DuPont; Frederick Vivino; Alan N Baer; Gui-Shuang Ying; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3944.

ARVO Annual Meeting Abstract June 2022

The effect of finasteride on dry eye disease

Brian Jonathan Nguyen; Elana Meer; Angela S Gupta; Gao Jinpeng; Gui-Shuang Ying; Vatinee Y Bunya; Ilaria Macchi; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):427.

ARVO Annual Meeting Abstract June 2022

Correction of accommodative and non-strabismic binocular visual dysfunction in the treatment of multifactorial dry eye disease

Angela Satya Gupta; Brian Jonathan Nguyen; Di Zhu; Laura Lehman; Melissa Richard; Julia Zyrina; Vatinee Y Bunya; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1516 – A0241.

ARVO Annual Meeting Abstract June 2022

Sex-Related Differences and Hormonal Effects in the Dry Eye Assessment and Management (DREAM) Study

Megan Zhao; Yinxi Yu; Neeta Roy; Gui-Shuang Ying; Penny A Asbell; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1511 – A0236.

ARVO Annual Meeting Abstract June 2021

Systemic conditions associated with the severity of dry eye signs and symptoms in the Dry Eye Assessment and Management (DREAM) Study

Kimberley Yu; Vatinee Y Bunya; Maureen G Maguire; Penny A Asbell; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1223.

ARVO Annual Meeting Abstract June 2021

Assessment of the Inclusion of Novel Autoantibodies into a Prediction Model to Screen Dry Eye Patients for Sjogren's Syndrome: Preliminary Findings

Kennedy Noel Johnson; Gui-Shuang Ying; Alexis Girón; Frederick Vivino; Soo Abboud; Franz Fogt; Mina Massaro-Giordano; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1221.

ARVO Annual Meeting Abstract June 2021

Clinical characteristics and treatment for dupilumab-related ocular complications in atopic dermatitis patients

Stephanie E. Jinno; Caroline W. Chung; Zujaja Tauqeer; Mina Massaro-Giordano; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1237.

ARVO Annual Meeting Abstract June 2021

Effect of Autologous Platelet-rich Plasma Eye Drops in the Treatment of Dry Eye Disease (DED)

Jennifer Beth Nadelmann; Vatinee Y Bunya; Gui-Shuang Ying; Peiying Hua; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1234.

ARVO Annual Meeting Abstract June 2020

Validation of a New Questionnaire to Screen Dry Eye Patients for Sjögren's Syndrome: preliminary findings

Kennedy Johnson; Gui-Shuang Ying; Jonathan Lilley; Frederick Vivino; Soo Abboud; Franz Fogt; Mina Massaro-Giordano; Vatinee Y Bunya

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):108.

ARVO Annual Meeting Abstract June 2020

Effect of topical recombinant human nerve growth factor (cenegermin) on corneal sensitivity in patients with neurotrophic keratitis

Mina Massaro-Giordano; Ilaria Macchi; Vatinee Y Bunya; Flavio Mantelli

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):380.

ARVO Annual Meeting Abstract June 2020

Efficacy of an Intranasal Tear Neurostimulator in Sjogren’s Syndrome Patients

Jonathan Lilley; Erin O'Neil; Vatinee Y Bunya; Kennedy Johnson; Gui-Shuang Ying; Peiying Hua; Ilaria Macchi; Mina Massaro-Giordano

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):98.

ARVO Annual Meeting Abstract June 2020

Association of Meibomian Gland Morphology with the Severity of Symptoms and Signs of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Ebenezer Daniel; Maxwell Pistilli; Penny A Asbell; Vatinee Y Bunya; Giacomina M Massaro-Giordano; Gui-Shuang Ying; Maureen Maguire

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):344.

ARVO Annual Meeting Abstract July 2019

A Brief Questionnaire to Screen Dry Eye Patients for Sjogren's Syndrome

Vatinee Y Bunya; Mina Massaro-Giordano; Frederick B Vivino; esen akpek; Alan Baer; John Alexander Gonzales; Tom Lietman; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6777.

ARVO Annual Meeting Abstract July 2019

Overall and Cancer-Related Mortality in the Sjögren’s International Collaborative Clinical Alliance (SICCA)

John Alexander Gonzales; Jaskirat Takhar; Vatinee Y Bunya; Jennifer Rose-Nussbaumer; Annie Chou; Lindsey Criswell; Caroline Shiboski; Tom Lietman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6506.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Bilamellar Tarsal Rotation (BLTR) vs Posterior Lamellar Tarsal Rotation (PLTR) for Trachomatous Trichiasis (TT)

Impact of Varenicline Solution Nasal Spray on Tear Film Cytokine Levels in Subjects with Sjogren’s Disease

Sjögren's Versus Non-Sjögren's Ocular Features: Similar Symptoms, But Significantly Worse Signs

Efficacy of OC-01 0.03mg varenicline nasal spray in the treatment of Sjogren’s Disease

Corneal Epithelial Thickness in Sjogren’s Syndrome

Two-Year Progression of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

Increased prevalence of novel antibodies in Sjögren’s patients compared to non-Sjögren’s dry eye patients

The effect of finasteride on dry eye disease

Correction of accommodative and non-strabismic binocular visual dysfunction in the treatment of multifactorial dry eye disease

Sex-Related Differences and Hormonal Effects in the Dry Eye Assessment and Management (DREAM) Study

Systemic conditions associated with the severity of dry eye signs and symptoms in the Dry Eye Assessment and Management (DREAM) Study

Assessment of the Inclusion of Novel Autoantibodies into a Prediction Model to Screen Dry Eye Patients for Sjogren's Syndrome: Preliminary Findings

Clinical characteristics and treatment for dupilumab-related ocular complications in atopic dermatitis patients

Effect of Autologous Platelet-rich Plasma Eye Drops in the Treatment of Dry Eye Disease (DED)

Validation of a New Questionnaire to Screen Dry Eye Patients for Sjögren's Syndrome: preliminary findings

Effect of topical recombinant human nerve growth factor (cenegermin) on corneal sensitivity in patients with neurotrophic keratitis

Efficacy of an Intranasal Tear Neurostimulator in Sjogren’s Syndrome Patients

Association of Meibomian Gland Morphology with the Severity of Symptoms and Signs of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study

A Brief Questionnaire to Screen Dry Eye Patients for Sjogren's Syndrome

Overall and Cancer-Related Mortality in the Sjögren’s International Collaborative Clinical Alliance (SICCA)

To View More...

You must be signed into an individual account to use this feature.